BioBridgeXAll companies

Ambergen, Inc.

Biotechnology company · Watertown, Massachusetts, United States

Ambergen, Inc. is a biotechnology company headquartered in Watertown, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has received 58 US government small-business research awards (SBIR/STTR) from health agencies, $42 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2022.

www.ambergen.comProfile compiled from public records. Is this your company? Request a correction or update

Ambergen at a glance

Typebiotechnology company
HeadquartersWatertown, Massachusetts, United States
Earliest incorporation on record2022
Employees (self-reported, 2022)6
SEC CIK1923459

What does Ambergen do?

US government research funding

58 SBIR/STTR small-business research awards from US health agencies, $41.8 million in total (1996 to 2022). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute on Aging.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5 million sold (2022).

Frequently asked questions about Ambergen

Where is Ambergen headquartered?

Ambergen, Inc. is headquartered in Watertown, Massachusetts, United States.

What does Ambergen do?

Ambergen, Inc. is a biotechnology company.

When was Ambergen founded?

The earliest incorporation on record for Ambergen, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences